Cargando…

Effectiveness of Routine BCG Vaccination on Buruli Ulcer Disease: A Case-Control Study in the Democratic Republic of Congo, Ghana and Togo

BACKGROUND: The only available vaccine that could be potentially beneficial against mycobacterial diseases contains live attenuated bovine tuberculosis bacillus (Mycobacterium bovis) also called Bacillus Calmette-Guérin (BCG). Even though the BCG vaccine is still widely used, results on its effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, Richard Odame, Phanzu, Delphin Mavinga, Beissner, Marcus, Badziklou, Kossi, Luzolo, Elysée Kalundieko, Sarfo, Fred Stephen, Halatoko, Wemboo Afiwa, Amoako, Yaw, Frimpong, Michael, Kabiru, Abass Mohammed, Piten, Ebekalisai, Maman, Issaka, Bidjada, Bawimodom, Koba, Adjaho, Awoussi, Koffi Somenou, Kobara, Basile, Nitschke, Jörg, Wiedemann, Franz Xaver, Kere, Abiba Banla, Adjei, Ohene, Löscher, Thomas, Fleischer, Bernhard, Bretzel, Gisela, Herbinger, Karl-Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287572/
https://www.ncbi.nlm.nih.gov/pubmed/25569674
http://dx.doi.org/10.1371/journal.pntd.0003457
_version_ 1782351815049740288
author Phillips, Richard Odame
Phanzu, Delphin Mavinga
Beissner, Marcus
Badziklou, Kossi
Luzolo, Elysée Kalundieko
Sarfo, Fred Stephen
Halatoko, Wemboo Afiwa
Amoako, Yaw
Frimpong, Michael
Kabiru, Abass Mohammed
Piten, Ebekalisai
Maman, Issaka
Bidjada, Bawimodom
Koba, Adjaho
Awoussi, Koffi Somenou
Kobara, Basile
Nitschke, Jörg
Wiedemann, Franz Xaver
Kere, Abiba Banla
Adjei, Ohene
Löscher, Thomas
Fleischer, Bernhard
Bretzel, Gisela
Herbinger, Karl-Heinz
author_facet Phillips, Richard Odame
Phanzu, Delphin Mavinga
Beissner, Marcus
Badziklou, Kossi
Luzolo, Elysée Kalundieko
Sarfo, Fred Stephen
Halatoko, Wemboo Afiwa
Amoako, Yaw
Frimpong, Michael
Kabiru, Abass Mohammed
Piten, Ebekalisai
Maman, Issaka
Bidjada, Bawimodom
Koba, Adjaho
Awoussi, Koffi Somenou
Kobara, Basile
Nitschke, Jörg
Wiedemann, Franz Xaver
Kere, Abiba Banla
Adjei, Ohene
Löscher, Thomas
Fleischer, Bernhard
Bretzel, Gisela
Herbinger, Karl-Heinz
author_sort Phillips, Richard Odame
collection PubMed
description BACKGROUND: The only available vaccine that could be potentially beneficial against mycobacterial diseases contains live attenuated bovine tuberculosis bacillus (Mycobacterium bovis) also called Bacillus Calmette-Guérin (BCG). Even though the BCG vaccine is still widely used, results on its effectiveness in preventing mycobacterial diseases are partially contradictory, especially regarding Buruli Ulcer Disease (BUD). The aim of this case-control study is to evaluate the possible protective effect of BCG vaccination on BUD. METHODOLOGY: The present study was performed in three different countries and sites where BUD is endemic: in the Democratic Republic of the Congo, Ghana, and Togo from 2010 through 2013. The large study population was comprised of 401 cases with laboratory confirmed BUD and 826 controls, mostly family members or neighbors. PRINCIPAL FINDINGS: After stratification by the three countries, two sexes and four age groups, no significant correlation was found between the presence of BCG scar and BUD status of individuals. Multivariate analysis has shown that the independent variables country (p = 0.31), sex (p = 0.24), age (p = 0.96), and presence of a BCG scar (p = 0.07) did not significantly influence the development of BUD category I or category II/III. Furthermore, the status of BCG vaccination was also not significantly related to duration of BUD or time to healing of lesions. CONCLUSIONS: In our study, we did not observe significant evidence of a protective effect of routine BCG vaccination on the risk of developing either BUD or severe forms of BUD. Since accurate data on BCG strains used in these three countries were not available, no final conclusion can be drawn on the effectiveness of BCG strain in protecting against BUD. As has been suggested for tuberculosis and leprosy, well-designed prospective studies on different existing BCG vaccine strains are needed also for BUD.
format Online
Article
Text
id pubmed-4287572
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42875722015-01-12 Effectiveness of Routine BCG Vaccination on Buruli Ulcer Disease: A Case-Control Study in the Democratic Republic of Congo, Ghana and Togo Phillips, Richard Odame Phanzu, Delphin Mavinga Beissner, Marcus Badziklou, Kossi Luzolo, Elysée Kalundieko Sarfo, Fred Stephen Halatoko, Wemboo Afiwa Amoako, Yaw Frimpong, Michael Kabiru, Abass Mohammed Piten, Ebekalisai Maman, Issaka Bidjada, Bawimodom Koba, Adjaho Awoussi, Koffi Somenou Kobara, Basile Nitschke, Jörg Wiedemann, Franz Xaver Kere, Abiba Banla Adjei, Ohene Löscher, Thomas Fleischer, Bernhard Bretzel, Gisela Herbinger, Karl-Heinz PLoS Negl Trop Dis Research Article BACKGROUND: The only available vaccine that could be potentially beneficial against mycobacterial diseases contains live attenuated bovine tuberculosis bacillus (Mycobacterium bovis) also called Bacillus Calmette-Guérin (BCG). Even though the BCG vaccine is still widely used, results on its effectiveness in preventing mycobacterial diseases are partially contradictory, especially regarding Buruli Ulcer Disease (BUD). The aim of this case-control study is to evaluate the possible protective effect of BCG vaccination on BUD. METHODOLOGY: The present study was performed in three different countries and sites where BUD is endemic: in the Democratic Republic of the Congo, Ghana, and Togo from 2010 through 2013. The large study population was comprised of 401 cases with laboratory confirmed BUD and 826 controls, mostly family members or neighbors. PRINCIPAL FINDINGS: After stratification by the three countries, two sexes and four age groups, no significant correlation was found between the presence of BCG scar and BUD status of individuals. Multivariate analysis has shown that the independent variables country (p = 0.31), sex (p = 0.24), age (p = 0.96), and presence of a BCG scar (p = 0.07) did not significantly influence the development of BUD category I or category II/III. Furthermore, the status of BCG vaccination was also not significantly related to duration of BUD or time to healing of lesions. CONCLUSIONS: In our study, we did not observe significant evidence of a protective effect of routine BCG vaccination on the risk of developing either BUD or severe forms of BUD. Since accurate data on BCG strains used in these three countries were not available, no final conclusion can be drawn on the effectiveness of BCG strain in protecting against BUD. As has been suggested for tuberculosis and leprosy, well-designed prospective studies on different existing BCG vaccine strains are needed also for BUD. Public Library of Science 2015-01-08 /pmc/articles/PMC4287572/ /pubmed/25569674 http://dx.doi.org/10.1371/journal.pntd.0003457 Text en © 2015 Phillips et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Phillips, Richard Odame
Phanzu, Delphin Mavinga
Beissner, Marcus
Badziklou, Kossi
Luzolo, Elysée Kalundieko
Sarfo, Fred Stephen
Halatoko, Wemboo Afiwa
Amoako, Yaw
Frimpong, Michael
Kabiru, Abass Mohammed
Piten, Ebekalisai
Maman, Issaka
Bidjada, Bawimodom
Koba, Adjaho
Awoussi, Koffi Somenou
Kobara, Basile
Nitschke, Jörg
Wiedemann, Franz Xaver
Kere, Abiba Banla
Adjei, Ohene
Löscher, Thomas
Fleischer, Bernhard
Bretzel, Gisela
Herbinger, Karl-Heinz
Effectiveness of Routine BCG Vaccination on Buruli Ulcer Disease: A Case-Control Study in the Democratic Republic of Congo, Ghana and Togo
title Effectiveness of Routine BCG Vaccination on Buruli Ulcer Disease: A Case-Control Study in the Democratic Republic of Congo, Ghana and Togo
title_full Effectiveness of Routine BCG Vaccination on Buruli Ulcer Disease: A Case-Control Study in the Democratic Republic of Congo, Ghana and Togo
title_fullStr Effectiveness of Routine BCG Vaccination on Buruli Ulcer Disease: A Case-Control Study in the Democratic Republic of Congo, Ghana and Togo
title_full_unstemmed Effectiveness of Routine BCG Vaccination on Buruli Ulcer Disease: A Case-Control Study in the Democratic Republic of Congo, Ghana and Togo
title_short Effectiveness of Routine BCG Vaccination on Buruli Ulcer Disease: A Case-Control Study in the Democratic Republic of Congo, Ghana and Togo
title_sort effectiveness of routine bcg vaccination on buruli ulcer disease: a case-control study in the democratic republic of congo, ghana and togo
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287572/
https://www.ncbi.nlm.nih.gov/pubmed/25569674
http://dx.doi.org/10.1371/journal.pntd.0003457
work_keys_str_mv AT phillipsrichardodame effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT phanzudelphinmavinga effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT beissnermarcus effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT badzikloukossi effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT luzoloelyseekalundieko effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT sarfofredstephen effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT halatokowembooafiwa effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT amoakoyaw effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT frimpongmichael effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT kabiruabassmohammed effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT pitenebekalisai effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT mamanissaka effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT bidjadabawimodom effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT kobaadjaho effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT awoussikoffisomenou effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT kobarabasile effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT nitschkejorg effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT wiedemannfranzxaver effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT kereabibabanla effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT adjeiohene effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT loscherthomas effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT fleischerbernhard effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT bretzelgisela effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo
AT herbingerkarlheinz effectivenessofroutinebcgvaccinationonburuliulcerdiseaseacasecontrolstudyinthedemocraticrepublicofcongoghanaandtogo